New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 3, 2016 – Teva launched an authorized generic version of Sunovion’s Xopenex HFA (levalbuterol tartrate) 45 mcg/actuation inhalation aerosol.
Download PDF
Return to publications
